On May 11, 2026, Health Secretary Robert F. Kennedy Jr. fired John Wong and Esa Davis, the two vice chairs of the U.S. Preventive Services Task Force, according to letters obtained by The Hill. Kennedy provided no detailed justification in the termination letters beyond citing a "review" of the leaders' work. The USPSTF is an independent, volunteer panel of medical experts that evaluates clinical evidence and issues recommendations on which preventive services—including cancer screenings, cardiovascular assessments, and vaccinations—should be covered without cost-sharing by insurance plans. The task force's recommendations carry significant weight across the healthcare system and directly influence coverage decisions affecting tens of millions of Americans.

The firings directly impact the USPSTF's ability to function as an independent scientific body. Wong and Davis were among the most influential voices on the panel, and their removal signals potential ideological restructuring of the task force. As interim leaders depart, the administration gains opportunity to appoint replacement members aligned with its priorities. This affects concrete healthcare decisions for millions: which preventive screenings insurance must cover for free, which vaccines are recommended without patient cost, and which early-detection services remain accessible to the uninsured or underinsured populations.

This action fits a broader pattern of the Trump administration dismantling independent health and scientific oversight mechanisms. Similar to the closure of the Immigration Detention Ombudsman office that removed watchdog accountability from detention facilities, the removal of USPSTF leadership eliminates independent scientific judgment from healthcare policy. The firings also echo the administration's restriction of DACA protections and its use of health emergencies to justify broad policy changes, as seen in the Congo and Uganda travel restrictions. By replacing independent medical experts with politically aligned appointees, the administration shifts preventive healthcare decisions from evidence-based medicine toward ideological considerations.

No court has yet blocked these terminations, and no legal challenges have been publicly filed. However, the action may trigger congressional scrutiny, particularly from Democrats concerned about politicization of healthcare. The USPSTF's statutory independence could become a legal issue if the administration attempts to override its recommendations through regulatory action. Reversal would require either Kennedy's replacement by a health secretary committed to scientific independence or congressional legislation explicitly protecting USPSTF autonomy from political interference.